i invested in MSB and just became aware of CYP over the weekend. I think CYP has great technology that addresses FDA concerns, however I am struggling to understand how advance is CYP manufacturing process comparing with Lonza. My understanding is that CYP is more vertical, because MSB has to get Lonza to do the manufacturing? i tried to read Lonza's paper published in mid 2010s re producing FDA compliant stem cells but not smart enough to understand that…
i invested in MSB and just became aware of CYP over the weekend....
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $38.81M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.5¢ | $1.505K | 7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 238227 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 27500 | 1 |
View Market Depth
| Last trade - 15.38pm 22/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |